live-3d-cell-immunocytochemistry-assays-pediatric-diffuse-midline

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Cell migration and invasion are specific hallmarks of Diffuse Midline Glioma (DMG) H3K27M-mutant tumors. We have already modeled these features using ...

IRCCS

The intratumor heterogeneity represents one of the most difficult challenges for the development of effective therapies to treat pediatric glioblastoma (pGBM) and diffuse intrinsic pontine glioma (DIPG). These brain tumors are composed of heterogeneous cell subpopulations that coexist and cooperate to build a functional network responsible for their aggressive phenotype. Understanding the cellular and molecular mechanisms sustaining such network will be crucial for the identification of new therapeutic strategies. To study more in-depth these mechanisms, we sought to apply the Multifluorescent Marking Technology. We generated multifluorescent pGBM and DIPG bulk cell lines randomly expressing six different fluorescent proteins and from which we derived stable optical barcoded single cell-derived clones. In this study, we focused on the application of the Multifluorescent Marking Technology in 2D and 3D in vitro/ex vivo culture systems. We discuss how we integrated different multimodal fluorescence analysis platforms, identifying their strengths and limitations, to establish the tools that will enable further studies on the intratumor heterogeneity and interclonal interactions in pGBM and DIPG.

Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG.

The use of liquid biopsy is of potential high importance for children with high grade (HGG) and diffuse midline gliomas (DMG), particularly where surgical procedures are limited, and invasive biopsy sampling not without risk. To date, however, the evidence that detection of cell-free DNA (cfDNA) or circulating tumor DNA (ctDNA) could provide useful information for these patients has been limited, or contradictory.

Giulia Pericoli

Department of Onco-hematology,
Gene and Cell Therapy,
Bambino Gesù Children's Hospital,
Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital

IRCCS

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Giulia Pericoli

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Onco-hematology,Gene and Cell Therapy,Bambino Gesù Children's Hospital,Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital

IRCCS

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Department of Onco-hematology,
Gene and Cell Therapy,
Bambino Gesù Children's Hospital,
Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital